Jenny Xie

3.4k total citations · 1 hit paper
19 papers, 1.8k citations indexed

About

Jenny Xie is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jenny Xie has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Jenny Xie's work include Immune Cell Function and Interaction (6 papers), Sphingolipid Metabolism and Signaling (6 papers) and Lipid Membrane Structure and Behavior (3 papers). Jenny Xie is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Sphingolipid Metabolism and Signaling (6 papers) and Lipid Membrane Structure and Behavior (3 papers). Jenny Xie collaborates with scholars based in United States, Sweden and China. Jenny Xie's co-authors include Hugh Rosen, Elizabeth J. Quackenbush, Kathleen M. Rupprecht, Gan-Ju Shei, William H. Parsons, James A. Milligan, Mark Rosenbach, Jeffrey J. Hale, James D. Bergstrom and Suzanne Mandala and has published in prestigious journals such as Science, The Journal of Immunology and Gastroenterology.

In The Last Decade

Jenny Xie

19 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

2002 1.4k citations Suzanne Mandala, Richard Hajdu et al. Science profile →

Peers

Countries citing papers authored by Jenny Xie

Since Specialization

Citations

This map shows the geographic impact of Jenny Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Xie more than expected).

Fields of papers citing papers by Jenny Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Xie. The network helps show where Jenny Xie may publish in the future.

Co-authorship network of co-authors of Jenny Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Xie. A scholar is included among the top collaborators of Jenny Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Xie. Jenny Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Development of circular AAV cargos for targeted seamless insertion with large serine integrases 2025 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), (unknown), Dev Paudel, (unknown), (unknown), (unknown), (unknown), (unknown), Yijun Zhang, Jesse C. Cochrane, Jonathan D. Finn, Jenny Xie	1
2	Pathogen-associated T follicular helper cell plasticity is critical in anti-viral immunity 2022 ·Science China Life Sciences ·Feng Han, Xiaohong Zhao, Jenny Xie, Xue Bai, Weiwei Fu, Hairong Chen, Hong Tang, Xiaohu Wang, Chen Dong	6
3	Systematic characterization of the tumor microenvironment in Chinese patients with hepatocellular carcinoma highlights intratumoral B cells as a potential immunotherapy target 2021 ·Oncology Reports ·Feng Yu, Liguo Liu, Jing Li, Jia Huang, Jenny Xie, Laurence Ménard, (unknown), Xiaohong Zhao, Shan Xie, Wenjuan Zang, Haidong Tan, Zhiying Yang, Ling Ni	12
4	Population Pharmacokinetic Analysis of BMS‐986166, a Novel Selective Sphingosine‐1‐Phosphate‐1 Receptor Modulator, and Exposure‐Response Assessment of Lymphocyte Counts and Heart Rate in Healthy Participants 2020 ·Clinical Pharmacology in Drug Development ·(unknown), Shalabh Singhal, Diane E. Shevell, Huadong Sun, Jenny Xie, (unknown), (unknown), Santanu Dutta, Elizabeth Ludwig, Hannah Huang, (unknown), Aberra Fura, John Throup, Ihab Girgis	1
5	The safety and pharmacokinetics of a novel, selective S1P1R modulator in healthy participants 2020 ·Expert Opinion on Investigational Drugs ·Shalabh Singhal, Ihab Girgis, Jenny Xie, Santanu Dutta, Diane E. Shevell, John Throup	2
6	Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P₁) Modulators: Optimization of the PK, PD, and Safety Profiles 2020 ·ACS Medicinal Chemistry Letters ·Zili Xiao, Michael G. Yang, T. G. Murali Dhar, Hai‐Yun Xiao, John L. Gilmore, David Marcoux, Kim W. McIntyre, (unknown), Hong Shi, Paul Lévesque, Anthony M. Marino, Georgia Cornelius, Arvind Mathur, Ding Ren Shen, Mary Ellen Cvijic, Lois D. Lehman‐McKeeman, Huadong Sun, Jenny Xie, Percy H. Carter, Alaric J. Dyckman	4
7	Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms 2020 ·Diabetes ·(unknown), Jen Bon Lui, Rosmely Hernandez, Liping Yu, Mary Struthers, Jenny Xie, (unknown), Connor J. Dwyer, Sunnie Hsiung, Aixin Yu, Thomas R. Malek	29
8	THU0190 THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF BMS-986166, A NOVEL, SELECTIVE, PARTIAL AGONIST OF THE SPHINGOSINE-1-PHOSPHATE (S1P) SUBTYPE 1 RECEPTOR IN HEALTHY PARTICIPANTS 2019 ·Annals of the Rheumatic Diseases ·Shalabh Singhal, Ihab Girgis, Jenny Xie, Santanu Dutta, Diane E. Shevell, John Throup	3
9	349 - BMS-986165 is a Highly Potent and Selective Allosteric Inhibitor of TYK2, Blocks Il-12, IL-23 and type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Inflammatory Bowel Disease 2018 ·Gastroenterology ·Jenny Xie, Kathleen M. Gillooly, (unknown), Xiaoxia Yang, Adriana Zupa-Fernandez, Lihong Cheng, Joann Strnad, Elizabeth Heimrich, (unknown), Jing Chen, Charu Chaudhry, Sha Li, Ryan Moslin, Stephen T. Wrobleski, James R. Burke	18
10	Preclinical mechanistic and efficacy evaluation of a novel small molecule TLR7 agonist RO7020531 for the treatment of chronic hepatitis B 2018 ·Journal of Hepatology ·(unknown), Xing Yu, (unknown), Long-Jun Gu, Jing Zhao, Liehuang Zhu, Giorgio Ottaviani, Hee Yun, Malika Ait‐Goughoulte, Mariola Ilnicka, Jenny Xie, (unknown), Aiguo Feng, Jason C. Young, (unknown)	2
11	A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokines 2017 ·Journal of Leukocyte Biology ·Qihong Zhao, (unknown), Jian Pang, (unknown), Xiaoxia Yang, Jinhong Wang, Yunling Song, (unknown), Huadong Sun, Vangipuram S. Rangan, Shrikant Deshpande, Huaping Tang, Mary Ellen Cvijic, Richard A. Westhouse, Timothy Olah, Jenny Xie, Mary Struthers, Luisa Salter–Cid	53
12	Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Rajeev S. Bhide, (unknown), (unknown), Zheming Ruan, (unknown), Carolyn A. Weigelt, John S. Sack, Kevin Stefanski, Xiaomei Gu, Jenny Xie, (unknown), Stacey Skala, Donna L. Pedicord, Stefan Ruepp, T. G. Murali Dhar, Percy H. Carter, Luisa Salter–Cid, Michael A. Poss, Paul Davies	12
13	Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699 2015 ·Journal of Pharmacology and Experimental Therapeutics ·Zheng Yang, Haiqing Wang, Theodora W. Salcedo, Suzanne J. Suchard, Jenny Xie, Lumelle A. Schneeweis, Catherine Fleener, James D. Calore, (unknown), (unknown), A. David Rodrigues, Bruce D. Car, Punit H. Marathe, Steven G. Nadler	14
14	Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR Agonists 2014 ·SLAS DISCOVERY ·Ying‐Jie Zhu, John B. Watson, Mengjie Chen, Ding Ren Shen, Melissa Yarde, (unknown), Neil T. Burford, Andrew Alt, Sukhanya Jayachandra, Mary Ellen Cvijic, Litao Zhang, Alaric J. Dyckman, Jenny Xie, Jonathan C. O’Connell, Martyn Banks, Andrea D. Weston	10
15	Studying GPCR trafficking using automated HCS tools 2010 ·Ying‐Jie Zhu, (unknown), Andrew Alt, Jonathan C. O’Connell, Martyn Banks, Jenny Xie	1
16	A CCR2/CCR5-dual antagonist, BMS-A, offers a potential novel oral therapy for the treatment of autoimmune disease (92.6) 2009 ·The Journal of Immunology ·Qihong Zhao, Jian Pang, Kim W. McIntyre, (unknown), Robert Townsend, Jennifer Postelnek, (unknown), (unknown), Gregory D. Ford, Stacey Conarello, Jenny Xie, Paul Davies, Joel C. Barrish, James M. Trzăskos, Luisa Salter–Cid, Murray McKinnon, Sandhya Mandlekar, Percy Carter	2
17	Sphingosine-1-Phosphate Receptor Agonism Impairs the Efficiency of the Local Immune Response by Altering Trafficking of Naive and Antigen-Activated CD4+ T Cells 2003 ·The Journal of Immunology ·Jenny Xie, Naomi Nomura, Sam L. Koprak, Elizabeth J. Quackenbush, Michael J. Forrest, Hugh Rosen	100
18	Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation 2003 ·Journal of Leukocyte Biology ·Jenny Xie, Naomi Nomura, Min Lu, (unknown), (unknown), (unknown), Raymond Rosa, Jerry Di Salvo, John S. Mudgett, Laurence B. Peterson, Linda S. Wicker, Julie A. DeMartino	139
19	Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists breakdown → 2002 ·Science ·Suzanne Mandala, Richard Hajdu, James D. Bergstrom, Elizabeth J. Quackenbush, Jenny Xie, James A. Milligan, Rosemary Thornton, Gan-Ju Shei, Deborah Card, (unknown), Mark Rosenbach, Jeffrey J. Hale, Christopher L. Lynch, Kathleen M. Rupprecht, William H. Parsons, Hugh Rosen	1398

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact